phenyl acetate has been researched along with Choroid Neovascularization in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burnim, SB; Edin, ML; Fredrick, TW; Fu, Z; Gong, Y; Hammock, BD; Hellström, A; Lee, KS; Lih, FB; Liu, CH; Meng, SS; Moran, EP; Morss, PC; Saba, NJ; SanGiovanni, JP; Shao, Z; Smith, LE; Wang, Z; Zeldin, DC | 1 |
Haeussler-Sinangin, Y; Koch, FH; Koss, MJ; Scholtz, S; Singh, P | 1 |
2 other study(ies) available for phenyl acetate and Choroid Neovascularization
Article | Year |
---|---|
Cytochrome P450 Oxidase 2C Inhibition Adds to ω-3 Long-Chain Polyunsaturated Fatty Acids Protection Against Retinal and Choroidal Neovascularization.
Topics: Acetates; Angiogenesis Inhibitors; Animals; Aorta; Cells, Cultured; Choroidal Neovascularization; Cyclopropanes; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C8 Inhibitors; Disease Models, Animal; Endothelial Cells; Fatty Acids, Omega-3; Genotype; Humans; Hyperoxia; Lasers; Mice, Inbred C57BL; Mice, Transgenic; Neovascularization, Physiologic; Phenotype; Quinolines; Retinal Neovascularization; Retinopathy of Prematurity; Sulfides; Tissue Culture Techniques | 2016 |
Combined intravitreal pharmacosurgery in patients with occult choroidal neovascularization secondary to wet age-related macular degeneration.
Topics: Acetates; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections; Male; Middle Aged; Minerals; Pilot Projects; Prospective Studies; Sodium Chloride; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitrectomy; Vitreous Body; Wet Macular Degeneration | 2010 |